Amy L. Palmer

ROS-induced nanotherapeutic approach for ovarian cancer treatment based on the combinatorial effect of photodynamic therapy and DJ-1 gene suppression

Canan Schumann, Olena Taratula, Oleh Khalimonchuk et al. · Nanomedicine Nanotechnology Biology and Medicine · 2015 · 40 citations

Nanomedicine, Nanotherapeutics, Ros-induced Nanotherapeutic Approach +10

Metabolism and Pharmacokinetics of the Anti-Tuberculosis Drug Ethionamide in a Flavin-Containing Monooxygenase Null Mouse

Amy L. Palmer, Virginia L. Leykam, Andrew L. Larkin et al. · Pharmaceuticals · 2012 · 16 citations · Full text

Pulmonary Tuberculosis, Pharmacological Study, Biochemistry +15

Enhanced Direct Major Histocompatibility Complex Class I Self-Antigen Presentation Induced by Chlamydia Infection

Erik D. Cram, Ryan S. Simmons, Amy L. Palmer et al. · Infection and Immunity · 2015 · 15 citations · Full text

Inhibition of the Deubiquitinase Usp14 Diminishes Direct MHC Class I Antigen Presentation

Amy L. Palmer, Annemieke de Jong, Yves Leestemaker et al. · The Journal of Immunology · 2017 · 15 citations · Full text

MHC Class I Antigen Presentation of DRiP-Derived Peptides from a Model Antigen Is Not Dependent on the AAA ATPase p97

Amy L. Palmer, Brian P. Dolan · PLoS ONE · 2013 · 11 citations · Full text